Our results regarding the adverse prognostic significance of high expression of Ang-2 by CLL cells are substantially in keeping with Hu¨ttmann et al. Importantly, in our series, CLL patients expressing at diagnosis high levels of Ang-2 usually had more advanced clinical stage and a higher percentage of CD38þ cells, had unmutated immunoglobulin status and unfavorable cytogenetics and had a shorter progression-free survival. These associations support the idea of the involvement of Ang-2 in the mechanisms of CLL disease progression. In addition, both circulating and BM-infiltrating Ig-unmutated CLL B-cells are able to express higher levels of Ang-2 than Ig-mutated CLL and normal B cells, suggesting the presence of an intrinsic defect in Ang-2 expression that could be pathogenetically relevant in CLL marrow microenvironment and could be involved in the differential clinical behavior of Ig-mutated and Ig-unmutated CLL cases.

Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status / Maffei R.; Marasca R.; Martinelli S.; Castelli I.; Santachiara R.; Morandi E.; Zucchini P.; Fontana M.; Giacobbi F.; Silingardi P.; Bonacorsi G.; Temperani P.; Masini L.; Colacci A.; Serra R.; Torelli G.. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 21:(2007), pp. 1312-1315. [10.1038/sj.leu.2404650]

Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status

MORANDI, ELENA;SILINGARDI, PAOLA;COLACCI, ANNAMARIA;
2007

Abstract

Our results regarding the adverse prognostic significance of high expression of Ang-2 by CLL cells are substantially in keeping with Hu¨ttmann et al. Importantly, in our series, CLL patients expressing at diagnosis high levels of Ang-2 usually had more advanced clinical stage and a higher percentage of CD38þ cells, had unmutated immunoglobulin status and unfavorable cytogenetics and had a shorter progression-free survival. These associations support the idea of the involvement of Ang-2 in the mechanisms of CLL disease progression. In addition, both circulating and BM-infiltrating Ig-unmutated CLL B-cells are able to express higher levels of Ang-2 than Ig-mutated CLL and normal B cells, suggesting the presence of an intrinsic defect in Ang-2 expression that could be pathogenetically relevant in CLL marrow microenvironment and could be involved in the differential clinical behavior of Ig-mutated and Ig-unmutated CLL cases.
2007
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status / Maffei R.; Marasca R.; Martinelli S.; Castelli I.; Santachiara R.; Morandi E.; Zucchini P.; Fontana M.; Giacobbi F.; Silingardi P.; Bonacorsi G.; Temperani P.; Masini L.; Colacci A.; Serra R.; Torelli G.. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 21:(2007), pp. 1312-1315. [10.1038/sj.leu.2404650]
Maffei R.; Marasca R.; Martinelli S.; Castelli I.; Santachiara R.; Morandi E.; Zucchini P.; Fontana M.; Giacobbi F.; Silingardi P.; Bonacorsi G.; Temperani P.; Masini L.; Colacci A.; Serra R.; Torelli G.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/103072
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact